A reader who trusts a piece of health information is trusting more than the words on the page – they are trusting that nothing behind the page shaped what was written. Funding transparency and conflict-of-interest disclosure are the least visible parts of editorial standards, and often the most consequential. This piece sets out the recognised UK frameworks for that kind of disclosure, and where this Review positions itself against them.
Why Funding Disclosure Is a Distinct Standard From Sourcing
Citing good evidence and being free of undisclosed influence are two different tests, and a publication can pass one while failing the other. An article can reference a robust study and still be shaped by who paid for the page it appears on – a commercial sponsor, an advertiser with a product to sell, or a commissioning body with an outcome it prefers. Conflict-of-interest disclosure exists to answer a question that citation alone cannot: not just “is this claim supported”, but “does anyone benefit financially from you believing it”.
The Recognised Frameworks for Health Content Disclosure
Several UK and international frameworks set out what funding transparency should look like in practice. None of them apply uniformly to every publisher, but together they describe the accepted baseline.
| Framework | Applies to | What it requires |
|---|---|---|
| PIF TICK (Patient Information Forum) | UK patient information producers | A transparency and legal criterion within its ten-point quality mark, assessed independently for print and digital content |
| HONcode (Health On the Net) | Health websites internationally (certification programme closed December 2022) | Financial Disclosure and Advertising Policy principles – name every funder, separate adverts from editorial content |
| ICMJE Disclosure Form | Authors submitting to biomedical journals | A 36-month look-back on financial relationships that could bias the submitted work |
| NICE Conflicts of Interest Policy | Experts and patient groups contributing to NICE guidance | Declaration of payments received in the 12 months prior to involvement from any organisation the decision could affect |
| UK National Screening Committee guidance | Advisers and members of the UK NSC | Declared interests managed on a scale from open disclosure to full exclusion from the relevant decision |
The detail differs – a 36-month window for journal authors, 12 months for NICE contributors, an open-ended “identify every funder” standard under the old HONcode – but the underlying discipline is consistent: name the money, and let the reader judge for themselves whether it matters.
Editorial Content Versus Advertising: Why the Line Has to Be Explicit
The retired HONcode’s Advertising Policy principle made a point worth keeping regardless of whether the certification itself still exists: if advertising funds a page, that has to be stated, and the advert has to be visually distinguishable from the editorial judgement around it. This matters more in health content than almost anywhere else, because the reader’s decision at stake – whether to trust a claim about a condition, a treatment, or a piece of equipment – carries real consequences. A funding note buried in a footer does not meet that bar in spirit, even where it might on a technicality.
Interests Are Not Always Financial
NHS England’s own guidance on declarations of interest makes a point that is easy to miss: an interest does not have to involve a payment to be worth disclosing. A non-financial interest – a personal relationship with an organisation being written about, a prior role advising a body whose work is under discussion, a strong prior public position on the exact question being covered – can shape a piece of writing just as much as a sponsorship arrangement, and arguably more quietly, because there is no invoice trail for a reader to ask about. The UK National Screening Committee’s guidance reflects the same logic in how it manages declared interests: not every conflict has to disqualify a contributor outright, but every one has to be named first, so that whoever is reading can weigh it rather than discover it later.
Where This Review Sits
This Review operates as an independent archive-and-commentary project. It is not the active Commission it takes its name from, not the Greater London Authority, not the NHS, and not affiliated with the office of the report’s original chair. It does not accept sponsored articles, does not sell a product referenced in its own coverage, and does not commission findings on behalf of a funder with a stake in the outcome. Where equipment or infrastructure topics are discussed, the framing stays at the level of what a system or standard requires – never a recommendation to buy from a named seller. That position is a deliberate editorial choice, not a formal certification, and readers should treat the distinction honestly: an independent stance is not the same as an audited one.
What This Means for Reading Any Health Information Site
The practical habit worth carrying from these frameworks is simple. Before weighing a claim on any health information page, look for who runs the site, whether it names its funding, and whether advertising – if present – is marked as such. A publisher that makes those answers easy to find is behaving the way PIF TICK, the old HONcode, and NICE’s own contributors are all asked to behave. One that makes them hard to find is asking for a kind of trust it has not actually earned.
Conclusion
Conflict-of-interest disclosure sits alongside sourcing and correction policy as a third pillar of editorial standards – distinct from either, and easy to overlook because it rarely shows up in the text itself. The frameworks above, from PIF TICK’s assessed criteria to NICE’s declared-interest windows, converge on the same principle: transparency about funding is not a courtesy, it is part of what makes a claim checkable. This Review holds itself to that principle as an independent, non-commercial publisher, and expects the same of anything it cites.